PET for Cancer
Additionally, in a National Coverage Determination for PET (FDG) for All Other Cancer Indications Not Previously Specified (220.6.15) the Centers for Medicare & Medicaid Services (CMS) determined that the evidence is sufficient to conclude that an FDG PET scan is reasonable and necessary only when the provider is participating in, and patients are enrolled in a prospective clinical studies that is designed to collect additional information at the time of the scan to assist in patient management.
|Facility name||Provider Number||Date Approved||State|
|The Cleveland Clinic Taussig Cancer Center||34-0714585||08/17/2007||OHIO|
|The Southwest Oncology Group (SWOG) and the American College of Radiology Imaging Network (ACRIN)||N/A||08/01/2007||ALABAMA|
- Page last Modified: 05/21/2012 9:34 AM
- Help with File Formats and Plug-Ins